Publications by authors named "Sabine Strommer"

16Publications

Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R.

PLoS One 2014 29;9(1):e84417. Epub 2014 Jan 29.

Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria ; Division of Hematology & Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article and Find Full Text PDF
September 2014

Synthesis and preclinical evaluation of the radiolabeled P-glycoprotein inhibitor [(11)C]MC113.

Nucl Med Biol 2012 Nov 13;39(8):1219-25. Epub 2012 Sep 13.

Health & Environment Department, Biomedical Systems, AIT Austrian Institute of Technology GmbH, Seibersdorf, Austria.

View Article and Find Full Text PDF
November 2012

Vertical inhibition of the mTORC1/mTORC2/PI3K pathway shows synergistic effects against melanoma in vitro and in vivo.

J Invest Dermatol 2011 Feb 4;131(2):495-503. Epub 2010 Nov 4.

Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, Medical University of Vienna, Vienna, Austria.

View Article and Find Full Text PDF
February 2011

mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo.

Anticancer Res 2008 Nov-Dec;28(6A):3801-8

Section of Experimental Oncology/Molecular Pharmacology, Department of Clinical Pharmacology, Medical University Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

View Article and Find Full Text PDF
March 2009

Everolimus (RAD001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivo.

Cancer Biol Ther 2008 Sep 2;7(9):1377-85. Epub 2008 Sep 2.

Section of Experimental Oncology/Molecular Pharmacology, Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria.

View Article and Find Full Text PDF
September 2008

Mcl-1 is a relevant molecular target for antisense oligonucleotide strategies in gastric cancer cells.

Cancer Biol Ther 2006 Oct 26;5(10):1348-54. Epub 2006 Oct 26.

Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, Medical University Vienna, Vienna, Austria.

View Article and Find Full Text PDF
October 2006

Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.

J Hepatol 2006 Jan 25;44(1):151-7. Epub 2005 Oct 25.

Section of Experimental Oncology/Molecular Pharmacology, Department of Clinical Pharmacology, Medical University Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

View Article and Find Full Text PDF
January 2006

Antitumor effect of G3139 Bcl-2 antisense oligonucleotide is independent of its immune stimulation by CpG motifs in SCID mice.

Antisense Nucleic Acid Drug Dev 2002 Dec;12(6):359-67

Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, University of Vienna, A-1090 Vienna, Austria.

View Article and Find Full Text PDF
December 2002